MoneyWorks4Me

Sharon Bio-Medicine informs about financial results

23 Feb 2018 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sharon Bio-Medicine has informed that the resolution professional on 22 February 2018 has approved and considered the standalone unaudited Financial results of the company with the Limited review report for the quarter and nine months ended December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..